UNIGE document Scientific Article
previous document  unige:104802  next document
add to browser collection

Hybrid PET-MRI in Alzheimer's Disease Research

Published in Methods in molecular biology. 2018, vol. 1750, p. 185-200
Abstract Multiple factors, namely amyloid, tau, inflammation, metabolic, and perfusion changes, contribute to the cascade of neurodegeneration and functional decline occurring in Alzheimer's disease (AD). These molecular and cellular processes and related functional and morphological changes can be visualized in vivo by two imaging modalities, namely positron emission tomography (PET) and magnetic resonance imaging (MRI). These imaging biomarkers are now part of the diagnostic algorithm and of particular interest for patient stratification and targeted drug development.In this field the availability of hybrid PET/MR systems not only offers a comprehensive evaluation in a single imaging session, but also opens new possibilities for the integration of the two imaging information. Here, we cover the clinical protocols and practical details of FDG, amyloid, and tau PET/MR imaging as applied in our institutions.
PMID: 29512073
Full text
Article (Published version) (821 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Laboratoire de neuroimagerie et de traceurs moléculaires innovants (984)
Optimisations des techniques avancés en neuroimagerie (985)
Troubles de mémoire et maladie d'Alzeimer (935)
(ISO format)
MAINTA, Ismini Charis et al. Hybrid PET-MRI in Alzheimer's Disease Research. In: Methods in Molecular Biology, 2018, vol. 1750, p. 185-200. doi: 10.1007/978-1-4939-7704-8_12 https://archive-ouverte.unige.ch/unige:104802

350 hits

1 download


Deposited on : 2018-05-31

Export document
Format :
Citation style :